0,1,2,3,4,5,6,7,8
RESEARCH ARTICLE,,,,,,,,
A,,,,,B,,,
,,,293T,,90,,,
,,,,,,Vector,,
,0 h,,24 h,48 h,,,,
,,,,,80,PLP2-TM,,
,,,,,,Rapamycin,,
eGFP-LC3B,,,,,70,,,
+,,,,,,,,
Vector,,,,,60,,,
,,,,,50,,,
eGFP-LC3B,,,,,Punctate cells (%),,,
,,,,,40,,,
+,,,,,,,,
PLP2-TM,,,,,30,,,
,,,,,20,,,
eGFP-LC3B,,,,,10,,,
+,,,,,,,,
Rapamycin,,,,,0,,,
,,,,,,24 h,,48 h
C,,,,,D,,,
,,,,,0.6,,,
,,PLP2-TM,,,,,,
,0 h,24 h,48 h,,0.5,,,
,,,,LC3-I,,,,
WB: LC3B,,,,LC3-II,0.4,,,
,,,,,"LC3-II/Actin
0.3",,,
WB: V5,,,,PLP2-TM,,,,
,,,,,0.2,,,
WB: β-Actin,,,,,,,,
,,,,β-Actin,0.1,,,
,,1         2         3,,,,,,
,,,,,0,,,
,,,,,,0 h,24 h,48 h
,,,,,,,PLP2-TM,
E,,,,,F,,,
,,,,,0.8,,,
Vector,+,-,-,,,,,
PLP2-TM,- -,+,+ +,,,,,
,,-,,,0.6,,,
3-MA,,,,,,,,
WB: LC3B,,,,LC3-I,,,,
,,,,LC3-II,"LC3-II/Actin
0.4",,,
WB: V5,,,,PLP2-TM,,,,
,,,,,0.2,,,
WB: β-Actin,,,,β-Actin,,,,
,,1         2          3,,,,,,
,,,,,0,,,
,,,,,PLP2-TM,--,+,++
,,,,,3-MA,,-,
